Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30


Whole-Exome and RNA-Sequencing Analyses of Acinic Cell Carcinomas of the Breast.

Beca F, Lee SSK, Pareja F, da Cruz Paula A, Selenica P, Ferrando L, Gularte-Merida R, Wen HY, Zhang H, Guerini-Rocco E, Rakha EA, Weigelt B, Reis-Filho JS.

Histopathology. 2019 Jul 30. doi: 10.1111/his.13962. [Epub ahead of print]


Outcome of radial scar/complex sclerosing lesion associated with epithelial proliferations with atypia diagnosed on breast core biopsy: results from a multicentric UK-based study.

Rakha E, Beca F, D'Andrea M, Abbas A, Petrou-Nunn W, Shaaban AM, Kandiyil A, Smith S, Menon S, Elsheikh S, ElSayed ME, Lee AH, Sharma N.

J Clin Pathol. 2019 Jul 26. pii: jclinpath-2019-205764. doi: 10.1136/jclinpath-2019-205764. [Epub ahead of print]


EN1 Is a Transcriptional Dependency in Triple-Negative Breast Cancer Associated with Brain Metastasis.

Peluffo G, Subedee A, Harper NW, Kingston N, Jovanović B, Flores F, Stevens LE, Beca F, Trinh A, Chilamakuri CSR, Papachristou EK, Murphy K, Su Y, Marusyk A, D'Santos CS, Rueda OM, Beck AH, Caldas C, Carroll JS, Polyak K.

Cancer Res. 2019 Aug 15;79(16):4173-4183. doi: 10.1158/0008-5472.CAN-18-3264. Epub 2019 Jun 25.


Ancillary Tests in Breast Cytology: A Practical Guide.

Beca F, Schmitt FC.

Acta Cytol. 2019;63(4):302-313. doi: 10.1159/000499697. Epub 2019 May 29. Review.


Predicting breast tumor proliferation from whole-slide images: The TUPAC16 challenge.

Veta M, Heng YJ, Stathonikos N, Bejnordi BE, Beca F, Wollmann T, Rohr K, Shah MA, Wang D, Rousson M, Hedlund M, Tellez D, Ciompi F, Zerhouni E, Lanyi D, Viana M, Kovalev V, Liauchuk V, Phoulady HA, Qaiser T, Graham S, Rajpoot N, Sjöblom E, Molin J, Paeng K, Hwang S, Park S, Jia Z, Chang EI, Xu Y, Beck AH, van Diest PJ, Pluim JPW.

Med Image Anal. 2019 May;54:111-121. doi: 10.1016/ Epub 2019 Feb 27. Erratum in: Med Image Anal. 2019 Aug;56:43.


SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression.

Zhang J, Chen M, Zhu Y, Dai X, Dang F, Ren J, Ren S, Shulga YV, Beca F, Gan W, Wu F, Lin YM, Zhou X, DeCaprio JA, Beck AH, Lu KP, Huang J, Zhao C, Sun Y, Gao X, Pandolfi PP, Wei W.

Dev Cell. 2019 Feb 11;48(3):329-344.e5. doi: 10.1016/j.devcel.2018.11.035. Epub 2018 Dec 27.


Androgen receptor expression in normal breast tissue and subsequent breast cancer risk.

Kensler KH, Beca F, Baker GM, Heng YJ, Beck AH, Schnitt SJ, Hazra A, Rosner BA, Eliassen AH, Hankinson SE, Brown M, Tamimi RM.

NPJ Breast Cancer. 2018 Sep 21;4:33. doi: 10.1038/s41523-018-0085-3. eCollection 2018.


Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer.

Ehteshami Bejnordi B, Veta M, Johannes van Diest P, van Ginneken B, Karssemeijer N, Litjens G, van der Laak JAWM; the CAMELYON16 Consortium, Hermsen M, Manson QF, Balkenhol M, Geessink O, Stathonikos N, van Dijk MC, Bult P, Beca F, Beck AH, Wang D, Khosla A, Gargeya R, Irshad H, Zhong A, Dou Q, Li Q, Chen H, Lin HJ, Heng PA, Haß C, Bruni E, Wong Q, Halici U, Öner MÜ, Cetin-Atalay R, Berseth M, Khvatkov V, Vylegzhanin A, Kraus O, Shaban M, Rajpoot N, Awan R, Sirinukunwattana K, Qaiser T, Tsang YW, Tellez D, Annuscheit J, Hufnagl P, Valkonen M, Kartasalo K, Latonen L, Ruusuvuori P, Liimatainen K, Albarqouni S, Mungal B, George A, Demirci S, Navab N, Watanabe S, Seno S, Takenaka Y, Matsuda H, Ahmady Phoulady H, Kovalev V, Kalinovsky A, Liauchuk V, Bueno G, Fernandez-Carrobles MM, Serrano I, Deniz O, Racoceanu D, Venâncio R.

JAMA. 2017 Dec 12;318(22):2199-2210. doi: 10.1001/jama.2017.14585.


Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.

Dai X, Gan W, Li X, Wang S, Zhang W, Huang L, Liu S, Zhong Q, Guo J, Zhang J, Chen T, Shimizu K, Beca F, Blattner M, Vasudevan D, Buckley DL, Qi J, Buser L, Liu P, Inuzuka H, Beck AH, Wang L, Wild PJ, Garraway LA, Rubin MA, Barbieri CE, Wong KK, Muthuswamy SK, Huang J, Chen Y, Bradner JE, Wei W.

Nat Med. 2017 Sep;23(9):1063-1071. doi: 10.1038/nm.4378. Epub 2017 Aug 14.


Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.

Gil Del Alcazar CR, Huh SJ, Ekram MB, Trinh A, Liu LL, Beca F, Zi X, Kwak M, Bergholtz H, Su Y, Ding L, Russnes HG, Richardson AL, Babski K, Min Hui Kim E, McDonnell CH 3rd, Wagner J, Rowberry R, Freeman GJ, Dillon D, Sorlie T, Coussens LM, Garber JE, Fan R, Bobolis K, Allred DC, Jeong J, Park SY, Michor F, Polyak K.

Cancer Discov. 2017 Oct;7(10):1098-1115. doi: 10.1158/2159-8290.CD-17-0222. Epub 2017 Jun 26.


EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses' Health Studies.

Beca F, Kensler K, Glass B, Schnitt SJ, Tamimi RM, Beck AH.

Breast Cancer Res. 2017 Mar 2;19(1):21. doi: 10.1186/s13058-017-0817-6.


Aspirin Suppresses Growth in PI3K-Mutant Breast Cancer by Activating AMPK and Inhibiting mTORC1 Signaling.

Henry WS, Laszewski T, Tsang T, Beca F, Beck AH, McAllister SS, Toker A.

Cancer Res. 2017 Feb 1;77(3):790-801. doi: 10.1158/0008-5472.CAN-16-2400. Epub 2016 Dec 9.


Precision Cancer Diagnostics: Tracking Genomic Evolution in Clinical Trials.

Beca F, Beck AH.

PLoS Med. 2016 Dec 6;13(12):e1002177. doi: 10.1371/journal.pmed.1002177. eCollection 2016 Dec.


LINC00520 is induced by Src, STAT3, and PI3K and plays a functional role in breast cancer.

Henry WS, Hendrickson DG, Beca F, Glass B, Lindahl-Allen M, He L, Ji Z, Struhl K, Beck AH, Rinn JL, Toker A.

Oncotarget. 2016 Dec 13;7(50):81981-81994. doi: 10.18632/oncotarget.11962.


MicroRNA signatures in cytopathology: Are they ready for prime time?

Beca F, Schmitt F.

Cancer Cytopathol. 2016 Sep;124(9):613-5. doi: 10.1002/cncy.21728. Epub 2016 May 6. No abstract available.


Intratumor Heterogeneity in Breast Cancer.

Beca F, Polyak K.

Adv Exp Med Biol. 2016;882:169-89. doi: 10.1007/978-3-319-22909-6_7. Review.


Role of noninsulin therapies alone or in combination in chromosome 6q24-related transient neonatal diabetes: sulfonylurea improves but does not always normalize insulin secretion.

Carmody D, Beca FA, Bell CD, Hwang JL, Dickens JT, Devine NA, Mackay DJ, Temple IK, Hays LR, Naylor RN, Philipson LH, Greeley SA.

Diabetes Care. 2015 Jun;38(6):e86-7. doi: 10.2337/dc14-3056. No abstract available.


Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer.

Beca F, Pereira M, Cameselle-Teijeiro JF, Martins D, Schmitt F.

BMC Cancer. 2015 Apr 15;15:285. doi: 10.1186/s12885-015-1266-1.


Tumor heterogeneity: the Lernaean hydra of oncology?

Janiszewska M, Beca F, Polyak K.

Oncology (Williston Park). 2014 Sep;28(9):781-2, 784. No abstract available.


p-mTOR expression is associated with better prognosis in luminal breast carcinoma.

Beca F, Andre R, Martins DS, Bilhim T, Martins D, Schmitt F.

J Clin Pathol. 2014 Nov;67(11):961-7. doi: 10.1136/jclinpath-2014-202320. Epub 2014 Jul 22.


Primary relapse site pattern in women with triple-negative breast cancer.

Beca F, Santos R, Vieira D, Zeferino L, Dufloth R, Schmitt F.

Pathol Res Pract. 2014 Sep;210(9):571-5. doi: 10.1016/j.prp.2014.05.011. Epub 2014 May 22.


Metastatic breast cancer: mechanisms and opportunities for cytology.

Martins D, Beca F, Schmitt F.

Cytopathology. 2014 Aug;25(4):225-30. doi: 10.1111/cyt.12158. Epub 2014 Jun 2. Review.


Genotypes and prevalence of HPV single and multiple concurrent infections in women with HSIL.

Beca F, Pinheiro J, Rios E, Pontes P, Amendoeira I.

Diagn Cytopathol. 2014 Nov;42(11):919-23. doi: 10.1002/dc.23143. Epub 2014 Mar 13.


Growing indication for FNA to study and analyze tumor heterogeneity at metastatic sites.

Beca F, Schmitt F.

Cancer Cytopathol. 2014 Jul;122(7):504-11. doi: 10.1002/cncy.21395. Epub 2014 Jan 29.


Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: key events in the progression from an in situ to an invasive breast carcinoma.

Martins D, Beça FF, Sousa B, Baltazar F, Paredes J, Schmitt F.

Cell Cycle. 2013 Aug 15;12(16):2684-90. doi: 10.4161/cc.25794. Epub 2013 Jul 29.


Improved malignancy prediction by B3 breast lesions subclassification.

de Beça FF, Rasteiro C, Correia A, Costa S, Amendoeira I.

Ann Diagn Pathol. 2013 Oct;17(5):434-6. doi: 10.1016/j.anndiagpath.2013.05.003. Epub 2013 Jun 15.


Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types.

de Beça FF, Caetano P, Gerhard R, Alvarenga CA, Gomes M, Paredes J, Schmitt F.

J Clin Pathol. 2013 Mar;66(3):187-91. doi: 10.1136/jclinpath-2012-201169. Epub 2012 Oct 30.


Oral squamous cell carcinoma in a Crohn's disease patient taking azathioprine: case report and review of the literature.

Vilas-Boas F, Magro F, Balhau R, Lopes JM, Beça F, Eloy C, Lopes S, Macedo G.

J Crohns Colitis. 2012 Aug;6(7):792-5. doi: 10.1016/j.crohns.2012.03.004. Epub 2012 Mar 30. Review.


Training does not affect exhaled nitric oxide in competitive swimmers.

Moreira A, Delgado L, Haahtela T, Silva JA, Araújo L, Beça F, Fonseca J, Castel-Branco MG.

Allergy. 2008 May;63(5):623-4. doi: 10.1111/j.1398-9995.2008.01659.x. No abstract available.


Embarazo tubárico bilateral.


Rev Esp Obstet Ginecol. 1947 Jan-Feb;5(31):40-3. Undetermined Language. No abstract available.


Supplemental Content

Support Center